Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma
Clinical trial NCT00302757 · COMPLETED
Trial details
- NCT number
- NCT00302757
- Sponsor
- University Hospital Tuebingen
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.